1118341000202109: Product containing precisely ledipasvir 33.75 milligram and sofosbuvir 150 milligram/1 sachet conventional release oral granules (clinical drug)

• SNOMED CT Concept\Pharmaceutical / biologic product (product)\Medicinal product (product)\...
• \Medicinal product categorized by disposition (product)\Hepatitis C virus protein NS5B inhibitor-containing product\Product containing sofosbuvir (medicinal product)\Product containing sofosbuvir in oral dose form (medicinal product form)\Product containing ledipasvir and sofosbuvir in oral dose form (medicinal product form)\Product containing only ledipasvir and sofosbuvir in oral dose form (medicinal product form)\Ledipasvir 33.75 mg and sofosbuvir 150 mg oral granules sachet
• \Medicinal product categorized by disposition (product)\Hepatitis C virus protein NS5B inhibitor-containing product\Product containing sofosbuvir (medicinal product)\Product containing ledipasvir and sofosbuvir (medicinal product)\Ledipasvir and sofosbuvir only product\Product containing only ledipasvir and sofosbuvir in oral dose form (medicinal product form)\Ledipasvir 33.75 mg and sofosbuvir 150 mg oral granules sachet
• \Medicinal product categorized by disposition (product)\Hepatitis C virus protein NS5B inhibitor-containing product\Product containing sofosbuvir (medicinal product)\Product containing ledipasvir and sofosbuvir (medicinal product)\Product containing ledipasvir and sofosbuvir in oral dose form (medicinal product form)\Product containing only ledipasvir and sofosbuvir in oral dose form (medicinal product form)\Ledipasvir 33.75 mg and sofosbuvir 150 mg oral granules sachet
• \Medicinal product categorized by disposition (product)\Hepatitis C virus protein NS5A inhibitor-containing product\Product containing ledipasvir (medicinal product)\Product containing ledipasvir in oral dose form (medicinal product form)\Product containing ledipasvir and sofosbuvir in oral dose form (medicinal product form)\Product containing only ledipasvir and sofosbuvir in oral dose form (medicinal product form)\Ledipasvir 33.75 mg and sofosbuvir 150 mg oral granules sachet
• \Medicinal product categorized by disposition (product)\Hepatitis C virus protein NS5A inhibitor-containing product\Product containing ledipasvir (medicinal product)\Product containing ledipasvir and sofosbuvir (medicinal product)\Ledipasvir and sofosbuvir only product\Product containing only ledipasvir and sofosbuvir in oral dose form (medicinal product form)\Ledipasvir 33.75 mg and sofosbuvir 150 mg oral granules sachet
• \Medicinal product categorized by disposition (product)\Hepatitis C virus protein NS5A inhibitor-containing product\Product containing ledipasvir (medicinal product)\Product containing ledipasvir and sofosbuvir (medicinal product)\Product containing ledipasvir and sofosbuvir in oral dose form (medicinal product form)\Product containing only ledipasvir and sofosbuvir in oral dose form (medicinal product form)\Ledipasvir 33.75 mg and sofosbuvir 150 mg oral granules sachet
• \Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing transferase inhibitor (product)\Product containing nucleotidyltransferase inhibitor (product)\Product containing RNA polymerase inhibitor (product)\Product containing sofosbuvir (medicinal product)\Product containing sofosbuvir in oral dose form (medicinal product form)\Product containing ledipasvir and sofosbuvir in oral dose form (medicinal product form)\Product containing only ledipasvir and sofosbuvir in oral dose form (medicinal product form)\Ledipasvir 33.75 mg and sofosbuvir 150 mg oral granules sachet
• \Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing transferase inhibitor (product)\Product containing nucleotidyltransferase inhibitor (product)\Product containing RNA polymerase inhibitor (product)\Product containing sofosbuvir (medicinal product)\Product containing ledipasvir and sofosbuvir (medicinal product)\Ledipasvir and sofosbuvir only product\Product containing only ledipasvir and sofosbuvir in oral dose form (medicinal product form)\Ledipasvir 33.75 mg and sofosbuvir 150 mg oral granules sachet
• \Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\Product containing transferase inhibitor (product)\Product containing nucleotidyltransferase inhibitor (product)\Product containing RNA polymerase inhibitor (product)\Product containing sofosbuvir (medicinal product)\Product containing ledipasvir and sofosbuvir (medicinal product)\Product containing ledipasvir and sofosbuvir in oral dose form (medicinal product form)\Product containing only ledipasvir and sofosbuvir in oral dose form (medicinal product form)\Ledipasvir 33.75 mg and sofosbuvir 150 mg oral granules sachet
• \Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Carboxylic acid and/or carboxylic acid derivative-containing product\Product containing sofosbuvir (medicinal product)\...
• \Product containing sofosbuvir in oral dose form (medicinal product form)\Product containing ledipasvir and sofosbuvir in oral dose form (medicinal product form)\Product containing only ledipasvir and sofosbuvir in oral dose form (medicinal product form)\Ledipasvir 33.75 mg and sofosbuvir 150 mg oral granules sachet
• \Product containing ledipasvir and sofosbuvir (medicinal product)\Ledipasvir and sofosbuvir only product\Product containing only ledipasvir and sofosbuvir in oral dose form (medicinal product form)\Ledipasvir 33.75 mg and sofosbuvir 150 mg oral granules sachet
• \Product containing ledipasvir and sofosbuvir (medicinal product)\Product containing ledipasvir and sofosbuvir in oral dose form (medicinal product form)\Product containing only ledipasvir and sofosbuvir in oral dose form (medicinal product form)\Ledipasvir 33.75 mg and sofosbuvir 150 mg oral granules sachet
• \Product manufactured as oral dose form (product)\Product containing ledipasvir in oral dose form (medicinal product form)\Product containing ledipasvir and sofosbuvir in oral dose form (medicinal product form)\Product containing only ledipasvir and sofosbuvir in oral dose form (medicinal product form)\Ledipasvir 33.75 mg and sofosbuvir 150 mg oral granules sachet
• \Product manufactured as oral dose form (product)\Product containing sofosbuvir in oral dose form (medicinal product form)\Product containing ledipasvir and sofosbuvir in oral dose form (medicinal product form)\Product containing only ledipasvir and sofosbuvir in oral dose form (medicinal product form)\Ledipasvir 33.75 mg and sofosbuvir 150 mg oral granules sachet

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Sep 2023. Module: SNOMED CT core

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
12552971000202118	Ledipasvir 33.75 mg and sofosbuvir 150 mg oral granules sachet	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
12554731000202112	Product containing precisely ledipasvir 33.75 milligram and sofosbuvir 150 milligram/1 sachet conventional release oral granules (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core

Expanded Value Set

This concept is not in any reference sets

Back to Start